| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $15.50B | $16.32B | $15.47B |
| YoY Revenue Growth % | -5.0% | +5.4% | — |
| Gross Profit | -$120.0M | $574.0M | — |
| Gross Margin % | -0.8% | 3.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$378.0M | $463.0M | $147.0M |
| Operating Margin % | -2.4% | 2.8% | 0.9% |
| Net Income (GAAP) | -$51.0M | $2.15B | $139.0M |
| EBITDA (Normalized) | -$338.0M | $594.2M | $704.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$387.0M | $828.0M | $212.0M |
| Capital Expenditures (CapEx) | $50.0M | $164.0M | $696.3M |
| Free Cash Flow (FCF) | -$437.0M | $664.0M | -$484.3M |
| FCF Margin % | -2.8% | 4.1% | -3.1% |
| Return on Invested Capital (ROIC %) | -13.7% | 16.4% | 1.0% |
| Cash & Short-Term Equivalents | $2.13B | $2.83B | — |
| Total Debt (Short + Long Term) | $1.07B | $1.10B | $4.35B |
| Total Stockholders' Equity | $3.24B | $3.95B | $8.91B |